LANSHE JAMES C 3
3 · Cellteck Inc. · Filed Oct 22, 2012
Insider Transaction Report
Form 3
Cellteck Inc.CLTK
LANSHE JAMES C
Director
Holdings
Options to purchase Series B convertible preferred stock
Exercise: $2.50From: 2012-08-01Exp: 2015-08-01→ Common Stock (20,000,000 underlying)
Footnotes (1)
- [F1]The options were originally granted on August 1, 2012 as options to purchase up to 25,000 shares of common stock of Eos Petro, Inc. ("Eos") for Mr. Lanshe's services as a non-employee director of Eos. The options were subsequently converted into options to purchase up to 25,000 shares of Series B convertible preferred stock of Cellteck, Inc. ("Cellteck") on October 12, 2012 in connection with the merger of Cellteck and Eos. Each share of Series B convertible preferred stock automatically converts into 800 shares of common stock of Cellteck upon the filing of a certain amendment to Cellteck's Articles of Incorporation. The options vested immediately on the grant date.